ABSTRACT
The highly invasive behavior of glioblastoma cells contributes to the morbidity and mortality associated with these tumors. The integrin-mediated adhesion and migration of glioblastoma cells on brain matrix proteins is enhanced by stimulation with growth factors, including platelet-derived growth factor (PDGF). As focal adhesion kinase (FAK), a nonreceptor cytoplasmic tyrosine kinase, has been shown to promote cell migration in various other cell types, we analysed its role in glioblastoma cell migration. Forced overexpression of FAK in serum-starved glioblastoma cells plated on recombinant (rec)-osteopontin resulted in a twofold enhancement of basal migration and a ninefold enhancement of PDGF-BB-stimulated migration. Both expression of mutant FAK(397F) and the downregulation of FAK with small interfering (si) RNA inhibited basal and PDGF-stimulated migration. FAK overexpression and PDGF stimulation was found to increase the phosphorylation of the Crk-associated substrate (CAS) family member human enhancer of filamentation 1 (HEF1), but not p130CAS or Src-interacting protein (Sin)/Efs, although the levels of expression of these proteins was similar. Moreover downregulation of HEF1 with siRNA, but not p130CAS, inhibited basal and PDGF-stimulated migration. The phosphorylated HEF1 colocalized with vinculin and was associated almost exclusively with 0.1% Triton X-100 insoluble material, consistent with its signaling at focal adhesions. FAK overexpression promoted invasion through normal brain homogenate and siHEF1 inhibited this invasion. Results presented here suggest that HEF1 acts as a necessary and specific downstream effector of FAK in the invasive behavior of glioblastoma cells and may be an effective target for treatment of these tumors.
Subject(s)
Brain Neoplasms/pathology , Cell Movement/physiology , Focal Adhesion Kinase 1/metabolism , Glioblastoma/pathology , Neoplasm Invasiveness/pathology , Phosphoproteins/metabolism , Adaptor Proteins, Signal Transducing , Brain Neoplasms/metabolism , Cell Line, Tumor , Glioblastoma/metabolism , Humans , Immunoblotting , Phosphorylation , Platelet-Derived Growth Factor/metabolism , RNA, Small InterferingABSTRACT
Oncogenic Src proteins have been extensively studied to gain insight into the signaling mechanisms of Src. To better understand signaling through wild-type Src, we used an approach that involves activation of Src signaling through the binding of physiologic ligands to the Src SH3 domain. To this end, we used full-length and truncated versions of the multiadapter molecules Cas and Sin to activate c-Src, and we examined the intracellular pathways that mediate Src signaling under these conditions. We show that although all proteins bind to and are phosphorylated by c-Src, quantitative differences exist in the ability of the different ligands to activate c-Src signaling. In addition, we show that Sin- and Cas-induced Src signaling, as assayed by transcriptional activation, is exclusively mediated through a pathway that involves the adapter Crk and the GTP-binding protein Rap1. These data are in contrast to previous observations showing Ras to mediate signaling downstream of transforming Src alleles. In our system, we found that signaling through the oncogenic SrcY527 mutant is indeed mediated by Ras. In addition, we found that Rap1 also mediates oncogenic Src signaling. Our results show for the first time that Rap1 mediates c-Src kinase signaling and reveal mechanistic differences in the signaling properties of wild-type and transforming Src proteins.
Subject(s)
Drosophila Proteins , Insect Proteins/physiology , MAP Kinase Signaling System/physiology , Phosphoproteins/physiology , Proteins , Proto-Oncogene Proteins pp60(c-src)/physiology , rap1 GTP-Binding Proteins/physiology , Adaptor Proteins, Signal Transducing , Alleles , Amino Acid Substitution , Crk-Associated Substrate Protein , Humans , Ligands , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/metabolism , Neoplasm Proteins/physiology , Oncogenes , Peptide Fragments/metabolism , Phosphorylation , Protein Processing, Post-Translational , Proto-Oncogene Proteins/physiology , Proto-Oncogene Proteins c-crk , Proto-Oncogene Proteins pp60(c-src)/genetics , Recombinant Fusion Proteins/physiology , Retinoblastoma-Like Protein p130 , Sequence Deletion , Transcriptional Activation/physiology , Tumor Cells, Cultured , src Homology DomainsABSTRACT
To understand how protein-protein interactions mediated by the Src-SH3 domain affect c-Src signaling, we screened for proteins that interact with the Src-SH3. We found a novel protein, Sin (Src interacting or signal integrating protein), that binds to Src-SH3 with high affinity, contains numerous tyrosine residues in configurations suggestive of SH2-binding sites, and is related to the v-Src substrate p130Cas. In cotransfection assays, a small fragment of Sin retaining the Src-SH3-binding site and one tyrosine-containing motif induced c-Src activation as measured by a transcriptional reporter. Phosphorylation of the peptide on tyrosine by c-Src, as a consequence of Src-SH3 binding, was necessary for its stable interaction with c-Src in vivo and for transcriptional activation. Phosphorylation of multiple tyrosine-containing motifs found on Sin correlated with c-Crk and cellular phosphoprotein binding to Sin as well as increased c-Src activity. These data suggest that (1) SH2 and SH3 ligand sites on Sin cooperatively activate the signaling potential of c-Src, (2) Sin acts as both an activator and a substrate for c-Src, and (3) phosphorylated Sin may serve as a signaling effector molecule for Src by binding to multiple cellular proteins.
Subject(s)
Proto-Oncogene Proteins pp60(c-src)/metabolism , Proto-Oncogene Proteins/metabolism , Ubiquitin-Protein Ligases , src Homology Domains , Amino Acid Sequence , Binding Sites , Cell Adhesion , Cell Line , Humans , Molecular Sequence Data , Peptides/genetics , Peptides/metabolism , Phosphorylation , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-cbl , Signal TransductionABSTRACT
To study the binding specificity of Src homology 3 (SH3) domains, we have screened a mouse embryonic expression library for peptide fragments that interact with them. Several clones were identified that express fragments of proteins which, through proline-rich binding sites, exhibit differential binding specificity to various SH3 domains. Src-SH3-specific binding uses a sequence of 7 aa of the consensus RPLPXXP, in which the N-terminal arginine is very important. The SH3 domains of the Src-related kinases Fyn, Lyn, and Hck bind to this sequence with the same affinity as that of the Src SH3. In contrast, a quite different proline-rich sequence from the Btk protein kinase binds to the Fyn, Lyn, and Hck SH3 domains, but not to the Src SH3. Specific binding of the Abl SH3 requires a longer, more proline-rich sequence but no arginine. One clone that binds to both Src and Abl SH3 domains through a common site exhibits reversed binding orientation, in that an arginine indispensable for binding to all tested SH3 domains occurs at the C terminus. Another clone contains overlapping yet distinct Src and Abl SH3 binding sites. Binding to the SH3 domains is mediated by a common PXXP amino acid sequence motif present on all ligands, and specificity comes about from other interactions, often ones involving arginine. The rules governing in vivo usage of particular sites by particular SH3 domains are not clear, but one binding orientation may be more specific than another.
Subject(s)
Oligopeptides/metabolism , Proline/metabolism , Proto-Oncogene Proteins c-abl/metabolism , Proto-Oncogene Proteins pp60(c-src)/metabolism , Proto-Oncogene Proteins/metabolism , Amino Acid Sequence , Animals , Binding Sites/genetics , Consensus Sequence , Mice , Molecular Sequence Data , Protein Binding , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-abl/genetics , Proto-Oncogene Proteins c-crk , Proto-Oncogene Proteins pp60(c-src)/genetics , Sequence Homology, Amino Acid , Structure-Activity RelationshipABSTRACT
v-Src-induced increases in diglyceride are derived from phosphatidylcholine via a type D phospholipase (PLD) and a phosphatidic acid phosphatase. v-Src-induced PLD activity, as measured by PLD-catalyzed transphosphatidylation of phosphatidylcholine to phosphatidylethanol, is inhibited by GDP beta S, which inhibits G-protein-mediated intracellular signals. Similarly, v-Src-induced increases in diglyceride are also blocked by GDP beta S. In contrast to the PLD activity induced by v-Src, PLD activity induced by the protein kinase C agonist, 12-O-tetradecanoylphorbol-13-acetate (TPA), was insensitive to GDP beta S. Consistent with the involvement of a G protein in the activation of PLD activity by v-Src, GTP gamma S, a nonhydrolyzable analog of GTP that potentiates G-protein-mediated signals, strongly enhanced PLD activity in v-Src-transformed cells relative to that in parental BALB/c 3T3 cells. The effect of GTP gamma S on PLD activity in v-Src-transformed cells was observed only when cells were prelabeled with [3H]myristate, which is incorporated exclusively into phosphatidylcholine, the substrate for the v-Src-induced PLD. There was no difference in the effect of GTP gamma S-induced PLD activity on v-Src-transformed and BALB/c 3T3 cells when the cells were prelabeled with [3H]arachidonate, which is not incorporated into phospholipids that are substrates for the v-Src-induced PLD. Similarly, GDP beta S inhibited PLD activity in v-Src-transformed cells much more strongly than in BALB/c 3T3 cells when [3H]myristate was used to prelabel the cells. The GTP-dependent activation of PLD by v-Src was dependent upon the presence of ATP but was unaffected by either cholera or pertussis toxin. These data suggest that v-Src induces PLD activity through a phosphorylation event and is mediated by a cholera and pertussis toxin-insensitive G protein.
Subject(s)
GTP-Binding Proteins/metabolism , Oncogene Protein pp60(v-src)/metabolism , Phospholipase D/metabolism , 3T3 Cells , Adenine Nucleotides/pharmacology , Aluminum Compounds/pharmacology , Animals , Arachidonic Acid/metabolism , Avian Sarcoma Viruses/genetics , Benzoquinones , Cell Line, Transformed , Cholera Toxin/pharmacology , Enzyme Induction , Fluorides/pharmacology , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Guanosine Diphosphate/analogs & derivatives , Guanosine Diphosphate/pharmacology , Kinetics , Lactams, Macrocyclic , Mice , Mice, Inbred BALB C , Myristic Acid , Myristic Acids/metabolism , Phosphatidylcholines/biosynthesis , Phospholipase D/antagonists & inhibitors , Phospholipase D/biosynthesis , Protein-Tyrosine Kinases/antagonists & inhibitors , Quinones/pharmacology , Rifabutin/analogs & derivatives , Tetradecanoylphorbol Acetate/pharmacology , Thionucleotides/pharmacology , Virulence Factors, Bordetella/pharmacologyABSTRACT
v-Fps activates promoters under the control of the 12-O-tetradecanoyl phorbol 13-acetate (TPA) response element (TRE). The induction of TRE-mediated transcription by v-Fps was sensitive to a dominant-negative mutant of Ha-Ras. An activated derivative of Ha-Ras, v-Ha-Ras, also activated TRE-mediated transcription. v-Fps-induced TRE-mediated gene expression was sensitive to depleting cells of protein kinase C (PKC), whereas v-Ha-Ras-induced TRE-mediated transcription was insensitive to PKC depletion, suggesting that Ha-Ras functions downstream from PKC in v-Fps-induced TRE-mediated gene expression. Consistent with this hypothesis, the induction of TRE-mediated gene expression by phorbol esters that activate PKC directly was blocked by the dominant-negative Ha-Ras mutant. Thus, v-Fps-induced activation of TRE-mediated gene expression is via an intracellular signaling mechanism that is dependent upon both PKC and Ha-Ras and Ha-Ras functions downstream from PKC.
Subject(s)
Fusion Proteins, gag-onc/pharmacology , Gene Expression Regulation/drug effects , Genes, ras , Protein Kinase C/physiology , Protein-Tyrosine Kinases , Tetradecanoylphorbol Acetate/pharmacology , 3T3 Cells , Animals , Chloramphenicol O-Acetyltransferase/genetics , GTP-Binding Proteins/physiology , Mice , MutationABSTRACT
Activating the protein-tyrosine kinase activity of v-Fps leads to the rapid transcriptional activation of the Egr-1 gene, which encodes a mitogen-responsive transcription factor. Activation of Egr-1 by v-Fps was insensitive to protein kinase C depletion, suggesting that a protein kinase C-independent signal activated by v-Fps leads to the induction of Egr-1. Expression of v-Fps in transient expression assays induced Egr-1 promoter activation. v-HaRas and v-Raf also activated the Egr-1 promoter. To characterize HaRas and Raf-1 involvement in v-Fps-induced Egr-1 expression, we used recently characterized dominant negative mutants of HaRas and Raf-1. v-Fps-induced Egr-1 promoter activation was inhibited by the dominant negative mutants of both HaRas and Raf-1. v-HaRas-induced Egr-1 promoter activation was blocked by the negative Raf-1 mutant; however, v-Raf-1-induced Egr-1 promoter activation was unaffected by the inhibitory HaRas mutant. These data suggest that v-Fps activates a protein kinase C-independent intracellular signaling pathway that is dependent on both HaRas and Raf-1, where Raf-1 functions downstream of HaRas.
Subject(s)
DNA-Binding Proteins/biosynthesis , Immediate-Early Proteins , Oncogene Protein p21(ras)/physiology , Protein-Tyrosine Kinases/physiology , Proto-Oncogene Proteins/physiology , Signal Transduction , Transcription Factors/biosynthesis , Animals , Avian Sarcoma Viruses , Cell Line , Cell Line, Transformed , Cell Transformation, Viral , Early Growth Response Protein 1 , Enzyme Activation , Fusion Proteins, gag-onc/physiology , Gene Expression Regulation , Mutation , Promoter Regions, Genetic , Protein Kinase C/physiology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-raf , Rats , Recombinant Fusion Proteins/biosynthesisABSTRACT
v-Src activates promoters under the control of 12-O-tetradecanoylphorbol-13-acetate (TPA) response elements (TREs) and serum response elements (SREs) via two distinguishable intracellular signaling mechanisms. The induction of TRE- and SRE-mediated gene expression by v-Src could be distinguished by a differential sensitivity to depleting cells of protein kinase C (PKC) and to a dominant negative Raf-1 mutant. Thus, PKC depletion and the dominant negative Raf-1 mutant were able to distinguish two intracellular signaling mechanisms activated by v-Src. Both of these v-Src-induced intracellular signals were sensitive to a dominant negative mutant of Ha-Ras. These data suggest that Ha-Ras functions to coordinately regulate multiple intracellular signaling mechanisms activated by v-Src.
Subject(s)
Gene Expression Regulation , Genes, ras , Genes, src , Promoter Regions, Genetic , 3T3 Cells , Animals , Chloramphenicol O-Acetyltransferase/genetics , Chloramphenicol O-Acetyltransferase/metabolism , Cloning, Molecular , GTPase-Activating Proteins , Mice , Plasmids , Promoter Regions, Genetic/drug effects , Proteins/metabolism , Recombinant Proteins/metabolism , Restriction Mapping , Simplexvirus/enzymology , Simplexvirus/genetics , Tetradecanoylphorbol Acetate/pharmacology , Thymidine Kinase/genetics , Transcription, Genetic , Transfection , ras GTPase-Activating ProteinsABSTRACT
Egr-1, a mitogen-responsive transcription factor, is rapidly induced by v-Fps in the absence of protein synthesis. Thus, Egr-1 is a primary response to the protein-tyrosine kinase activity of v-Fps. To determine the v-Fps-responsive elements in the Egr-1 promoter, deletion mutants of the Egr-1 promoter were used in transient expression assays. A v-Fps expression vector was contransfected into NIH 3T3 cells with chloramphenicol acetyl transferase (CAT) gene expression vectors under the control of the Egr-1 promoter or the Egr-1 promoter containing various deletions. Responsiveness to v-Fps was restricted to a region that contained repeated CC(A/T)6GG sequences, known as CArG boxes. CArG boxes form the core of serum response element (SREs). v-Fps-induced Egr-1 promoter activation was lost by sequential removal of four tandemly repeated SREs. This region, containing four SREs, was found to be sufficient for maximal Egr-1 induction by v-Fps when placed upstream from a heterologous promoter. Individual SREs from this region were able to respond to v-Fps, however, the activation of the individual SREs was lower than that observed for the clustered SREs. These data suggest that v-Fps-responsiveness in the Egr-1 promoter is mediated by SREs.
Subject(s)
DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Fusion Proteins, gag-onc/metabolism , Immediate-Early Proteins , Nuclear Proteins/metabolism , Promoter Regions, Genetic , Protein-Tyrosine Kinases/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , 3T3 Cells , Animals , Cell Line , Early Growth Response Protein 1 , Gene Expression Regulation , Mice , Mutation , Plasmids , Rats , Serum Response Factor , TransfectionABSTRACT
Serum stimulation of quiescent fibroblasts leads to a transient induction of the transcription factor egr-1. However, the induction of egr-1 by v-src was found to be sustained rather than transient. The proto-oncogene fos has been reported to be co-regulated with egr-1 and to repress serum-induced egr-1 expression. We found that c-fos prevents v-src-induced gene expression regulated by the egr-1 promoter. Thus, the sustained induction of egr-1 by v-src could be explained by a lack of c-fos induction by v-src. Consistent with this hypothesis, egr-1 and c-fos were co-induced by serum, but not by v-src, in Balb/c 3T3 cells; v-src did not induce c-fos expression in these cells. We propose that sustained expression of egr-1 induced by v-src in Balb/c 3T3 cells is due to a lack of c-fos down-regulation of egr-1.
Subject(s)
DNA-Binding Proteins/metabolism , Gene Expression Regulation/physiology , Genes, fos/physiology , Genes, src/physiology , Immediate-Early Proteins , Transcription Factors/metabolism , 3T3 Cells , Animals , DNA-Binding Proteins/genetics , Early Growth Response Protein 1 , Mice , Transcription Factors/genetics , Transcription, GeneticABSTRACT
The protein-tyrosine kinase (PTK) v-Fps induces protein kinase C (PKC)-dependent expression of the transformation-related 9E3 gene in chicken embryo fibroblasts (Spangler, R., Joseph, C., Qureshi, S.A., Berg, K., and Foster, D.A. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 7017-7021). We present evidence here that a GTP-binding protein (G-protein) is a component of this PKC-dependent signaling pathway. 1) A GTP analogue that stimulates G-protein-mediated signals induced 9E3 gene expression. 2) A GDP analogue that inhibits signaling through G-proteins inhibited expression of 9E3 and phosphorylation of a 67-kDa PKC substrate induced by v-Fps. The GDP analogue had no effect on phosphorylation of the PKC substrate or the expression of 9E3 induced by direct activation of PKC with phorbol ester. 3) Increased v-Fps PTK activity led to increased GTP binding to a 50-kDa protein. The molecular weight of this GTP-binding protein is consistent with the molecular weight of alpha-subunits of G-proteins of the heterotrimeric class. The data suggest that a G-protein functions upstream from PKC in a signaling pathway that connects v-Fps PTK activity to increased 9E3 gene expression.
Subject(s)
Fusion Proteins, gag-onc/metabolism , GTP-Binding Proteins/metabolism , Protein-Tyrosine Kinases/metabolism , Signal Transduction , Animals , Chick Embryo , Cross-Linking Reagents , Enzyme Induction , Gene Expression , Phosphorylation , Protein Kinase C/biosynthesis , Protein Kinase C/genetics , Protein Kinase C/metabolism , RNA/analysis , Substrate SpecificityABSTRACT
Cholera toxin (CT) activates expression of two immediate-early response genes (JE and TIS10) in quiescent BALB/c 3T3 cells. Increases in cyclic AMP (cAMP) levels in response to CT are likely responsible for the induction of TIS10 gene expression, since treatment with 8-Br-cAMP and increasing the intracellular levels of cAMP by treatment with forskolin induce TIS10 gene expression. In contrast, neither forskolin nor 8-Br-cAMP induces JE gene expression. 3-Isobutyl-1-methylxanthine, which stabilizes intracellular cAMP, potentiates CT-induced TIS10 gene expression but has no effect on CT-induced JE gene expression. Thus, induction of JE by CT is independent of the cAMP produced in response to CT. Induction of JE by CT does not require protein kinase C (PKC), since depleting cells of PKC activity has no effect on the induction of JE by CT. CT-induced expression of JE can be distinguished from CT-induced TIS10 gene expression by using protein kinase inhibitors and inhibitors of arachidonic acid metabolism, further suggesting distinct signaling pathways for CT-induced JE and TIS10 gene expression. Thus, induction of JE gene expression by CT results from the activation of an intracellular signaling pathway that is independent of cAMP production. This pathway is independent of PKC activity and uniquely sensitive to inhibitors of protein kinases and arachidonic acid metabolism.
Subject(s)
Chemotactic Factors/genetics , Cholera Toxin/pharmacology , Gene Expression Regulation/drug effects , 1-Methyl-3-isobutylxanthine/pharmacology , Animals , Cell Line , Chemokine CCL2 , Colforsin/pharmacology , Cyclic AMP/physiology , Cyclooxygenase Inhibitors , GTP-Binding Proteins/physiology , Indomethacin/pharmacology , Lipoxygenase Inhibitors , Masoprocol/pharmacology , Mice , Phosphoproteins/metabolism , Phosphorylation , Protein Kinase C/physiology , Signal TransductionABSTRACT
Twenty-eight individuals with familial schizophrenia, from 16 unrelated families (12 sibling pairs and 4 individuals whose siblings refused scanning), and 21 normal control subjects were examined by cerebral magnetic resonance imaging (MRI). Measurements of the cerebrum, temporal lobes, and cerebral lateral ventricles were obtained using consecutive coronal sections containing these structures. Temporal lobe volume was significantly decreased by approximately 10% in these early onset schizophrenic siblings compared with normal controls. These findings add to recent post-mortem and neuroradiological evidence for morphological alteration in the temporal lobes in schizophrenia.